Yes: It is palliative not curative. The amount of life extension is based on each individual case
Answered 11/28/2017
3k views
In the right patient: Yes, in the appropriate clinical setting of 2nd, 3rd line and salvage therapy. Selective internal radiation therapy (SIRT/Y-90) is recommended for chemorefractory disease with liver-only or liver-predominant disease & in people who do not wish to have systemic chemotherapy. Since the median survival in failed 3rd line chemo patients is in the range of 4-6 mth, SIRT can extend survival to 10-12 mth
Answered 3/23/2019
640 views
7 doctors weighed in across 3 answers
6 doctors weighed in across 3 answers
5 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question